Dr Pierre Angier talks about the Tact EDTA Chelation Trials

Dr Pierre Angier talks about the Tact EDTA Chelation Trials. A 30 million dollar study that was funded by the NIH which looked at the effectiveness of EDTA, an amino acid that is used by alternative physicians to treat heart disease, there are 100,000 people a year receive this treatment.